Endoscopy 2020; 52(12): v48
DOI: 10.1055/a-1199-8799
Author commentary

Author commentary on Yuhang Zhang et al.

› Further Information
Also available at
    Permissions and Reprints

Yuhang Zhang et al. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial

This small randomized controlled trial showed that adjunctive radiotherapy following endoscopic submucosal dissection of T1a esophageal squamous cell carcinoma improved 3-year recurrence-free survival (100 % vs. 85.3 %; P = 0.04).

Quality:


Publication History

Article published online:
25 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Refers to:

Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled TrialEndoscopy 2020; 52(12): 1066-1074
DOI: 10.1055/a-1198-5232